Table 6 - Gain and loss: Human and environmental wellbeing – drivers of Kilimanjaro’s decreasing biodiversity by Andreas Hemp (730415)

Subjects:

Representative liver histopathology under H&E staining at increasing grades of fatty change. by Mohammadreza Khodaei (22493156)

Subjects:

Increased Iba-1 in mouse pups exposed to Pg-OMV during pregnancy. by Adrienne J. Bradley (20861948)

Subjects:

Pathway analysis using GRB2, a significantly connected and downregulated protein as the focus. by Eiman Y. Ibrahim (10731078)

Synaptopathy at IHC-SGN synapses decreases the peak of the CAP significantly, without changes to peak latency and width. by Maral Budak (6680351)

“…(C) Normalized CAP amplitudes exhibited an exponential increase and the decreases in CAP amplitudes of populations with both synaptopathy scenarios were more pronounced for higher sound levels. …”

Self-reported affect change during CFI for participants who attended multiple sessions (N = 22). by Iona Naismith (14581268)

Subjects:

Change in use of Warfarin and DOACs over time, financial incentives to encourage increased detection in the management of AF introduced in 2014. by Simon de Lusignan (2416)

Subjects:

Differences in PH levels of young children with increasing age [N (%)]. by Xin Xiong (113595)

Subjects:

Late onset DEG (identified at later timepoints) from significant pathways. by Sung-Hyun Park (196247)

Frequencies of peripheral blood immune cells with each profile in all patients before and after OBV/PTV/r therapy that did not change significantly. by Miyabi Miura (18605126)

Subjects:

Significant interaction VE*HT effects (q<0.10). by Hernán D. Laviano (19657315)

Image_1_Extrahepatic Surgery in Cirrhosis Significantly Increases Portal Pressure in Preclinical Animal Models.TIF by Johannes Chang (5081978)

“…In the non-cirrhotic model the trend was the same, while not statistically significant. In both cirrhotic models, IM shows strong effects of decompensation, with significant weight loss, elevation of liver enzymes and hypoalbuminemia. 7 days after IM in the BDL group, Sirius red staining and hydroxyproline levels showed significant progression of fibrosis and significantly elevated mRNA levels of hepatic inflammation compared to the respective control group. …”

Image_3_Extrahepatic Surgery in Cirrhosis Significantly Increases Portal Pressure in Preclinical Animal Models.TIF by Johannes Chang (5081978)

“…In the non-cirrhotic model the trend was the same, while not statistically significant. In both cirrhotic models, IM shows strong effects of decompensation, with significant weight loss, elevation of liver enzymes and hypoalbuminemia. 7 days after IM in the BDL group, Sirius red staining and hydroxyproline levels showed significant progression of fibrosis and significantly elevated mRNA levels of hepatic inflammation compared to the respective control group. …”

Image_2_Extrahepatic Surgery in Cirrhosis Significantly Increases Portal Pressure in Preclinical Animal Models.TIF by Johannes Chang (5081978)

“…In the non-cirrhotic model the trend was the same, while not statistically significant. In both cirrhotic models, IM shows strong effects of decompensation, with significant weight loss, elevation of liver enzymes and hypoalbuminemia. 7 days after IM in the BDL group, Sirius red staining and hydroxyproline levels showed significant progression of fibrosis and significantly elevated mRNA levels of hepatic inflammation compared to the respective control group. …”

Table_1_Extrahepatic Surgery in Cirrhosis Significantly Increases Portal Pressure in Preclinical Animal Models.docx by Johannes Chang (5081978)

“…In the non-cirrhotic model the trend was the same, while not statistically significant. In both cirrhotic models, IM shows strong effects of decompensation, with significant weight loss, elevation of liver enzymes and hypoalbuminemia. 7 days after IM in the BDL group, Sirius red staining and hydroxyproline levels showed significant progression of fibrosis and significantly elevated mRNA levels of hepatic inflammation compared to the respective control group. …”

Statistically significant differences in gut microbiome relative abundances. by Anju Saxena (12098170)

Subjects:

Linear covariate analysis of prognostically significant metabolites. Presenting the effect sizes of metabolites that showed significant differences among prognostic groups in ICU-treated COVID-19 patients. Metabolites were included based on an F-value > 2.5 and a p-value < 0.05. Metabolites marked with a single asterisk (*) were significant in both two-way ANOVA and ASCA, whereas those marked with double asterisks (**) were significant only in two-way ANOVA. Positive effect sizes indicate an increase in metabolite concentration between the compared groups, while negative values indicate a decrease. by Emir Matpan (21655811)

“…Positive effect sizes indicate an increase in metabolite concentration between the compared groups, while negative values indicate a decrease.…”

Statistically significant predictors (defined in Table 1) of migration status. by Douglas W. Morris (2902302)

Features that varied significantly with storage time. by Patrick Barko (10152481)

Subjects:

Summary of the effect of MPDD on SDLP across all participants, and also participants categorized by driving styles (“NS” (no significant), “+” (significant increase), and “-” (significant decrease)). by Mobina Faqani (22783963)

“…<p>Summary of the effect of MPDD on SDLP across all participants, and also participants categorized by driving styles (“NS” (no significant), “+” (significant increase), and “-” (significant decrease)).…”